未知机构：微创机器人B图迈订单破200台海外渗透持续提速-20260213

Summary of Key Points from the Conference Call Company Overview - The company discussed is MicroPort Scientific Corporation (微创机器人-B), focusing on its TUMAI surgical robot and its global commercialization efforts. Core Insights and Arguments - Order Milestone: As of February 12, 2026, the TUMAI surgical robot has surpassed 200 global commercial orders, with installations completed in nearly 50 countries and regions [1] - Installation Progress: The company has completed nearly 130 installations of the TUMAI surgical robot [1] - Geographical Distribution: Among the nearly 50 countries, 12 countries have more than 5 orders each. Notable orders include 14 units in India, over 10 units in Brazil, and growth in developed markets such as Spain and Australia [1] - Clinical Application Growth: Among the installed units, several centers have performed over 100 surgeries, indicating a deepening of clinical application across various specialties including urology, general surgery, thoracic surgery, and gynecology [1] Additional Important Content - Remote Surgery Expansion: The company has conducted nearly 800 remote surgeries across more than 20 countries, maintaining a 100% success rate. The remote system has received approvals in countries such as China, India, and Brazil, covering nearly half of the global population [2] - Order and Installation Timeline: - By December 31, 2024: Over 60 commercial orders and 30 installations - By October 8, 2025: Over 100 commercial orders and 80 installations - By December 24, 2025: Over 160 commercial orders and 100 installations - By January 21, 2026: Over 180 commercial orders and 120 installations - By February 12, 2026: Over 200 commercial orders and 130 installations [2]